Movement Disorders (revue)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Scales to Assess Sleep Impairment in Parkinson's Disease: Critique and Recommendations

Identifieur interne : 000786 ( PascalFrancis/Corpus ); précédent : 000785; suivant : 000787

Scales to Assess Sleep Impairment in Parkinson's Disease: Critique and Recommendations

Auteurs : Birgit Högl ; Isabelle Arnulf ; Cynthia Comella ; Joaquim Ferreira ; Alex Iranzo ; Barbara Tilley ; Claudia Trenkwalder ; Werner Poewe ; Olivier Rascol ; Cristina Sampaio ; Glenn T. Stebbins ; Anette Schrag ; Christopher G. Goetz

Source :

RBID : Pascal:11-0065107

Descripteurs français

English descriptors

Abstract

There is a broad spectrum of sleep disturbances observed in Parkinson's disease (PD). A variety of scales have been applied to the evaluation of PD sleep and wakefulness, but only a small number have been assessed specifically for clinimetric properties in the PD population. The movement disorder society has commissioned this task force to examine these scales and to assess their use in PD. A systematic literature review was conducted to explore the use of sleep scales in PD and to determine which scales qualified for a detailed critique. The task force members, all of whom have extensive experience in assessing sleep in PD reviewed each of the scales using a structured proforma. Scales were categorized into recommended, suggested and listed according to predefined criteria. A total of 48 potential scales were identified from the search and reviewed. Twenty-nine were excluded because they did not meet review criteria or were variations of scales already included, leaving 19 scales that were critiqued and rated by the task force based on the rating criteria. Only six were found to meet criteria for recommendation or suggestion by the task force: the PD sleep scale (PDSS) and the Pittsburgh sleep quality index (PSQI) are recommended for rating overall sleep problems to screen and to measure severity, the SCOPA-sleep (SCOPA) is recommended for rating overall sleep problems both to screen and to measure severity, and for rating daytime sleepiness ; the Epworth sleepiness scale (ESS) is recommended for rating daytime sleepiness to screen and to measure severity; the inappropriate sleep composite score (ISCS) is suggested for rating severe daytime sleepiness or sleep attacks to screen and to measure severity; and the Stanford sleepiness scale (SSS) is suggested for rating sleepiness and to measure severity at a specific moment. The task force does not recommend the development of new scales, but emphasizes the need for educational efforts to train physicians in sleep interview techniques and polysomnography.

Notice en format standard (ISO 2709)

Pour connaître la documentation sur le format Inist Standard.

pA  
A01 01  1    @0 0885-3185
A03   1    @0 Mov. disord.
A05       @2 25
A06       @2 16
A08 01  1  ENG  @1 Scales to Assess Sleep Impairment in Parkinson's Disease: Critique and Recommendations
A11 01  1    @1 HÖGL (Birgit)
A11 02  1    @1 ARNULF (Isabelle)
A11 03  1    @1 COMELLA (Cynthia)
A11 04  1    @1 FERREIRA (Joaquim)
A11 05  1    @1 IRANZO (Alex)
A11 06  1    @1 TILLEY (Barbara)
A11 07  1    @1 TRENKWALDER (Claudia)
A11 08  1    @1 POEWE (Werner)
A11 09  1    @1 RASCOL (Olivier)
A11 10  1    @1 SAMPAIO (Cristina)
A11 11  1    @1 STEBBINS (Glenn T.)
A11 12  1    @1 SCHRAG (Anette)
A11 13  1    @1 GOETZ (Christopher G.)
A14 01      @1 Department of Neurology, Innsbruck Medical University @2 Innsbruck @3 AUT @Z 1 aut. @Z 8 aut.
A14 02      @1 Unité des Pathologies du Sommeil, Hôpital Pitié-Salpêtrière @2 Paris @3 FRA @Z 2 aut.
A14 03      @1 UMR975, Université Paris VI @2 Paris @3 FRA @Z 2 aut.
A14 04      @1 Department of Neurological Sciences, Rush University Medical Center @2 Chicago, Illinois @3 USA @Z 3 aut. @Z 11 aut. @Z 13 aut.
A14 05      @1 Instituto de Medicina Molecular, University of Lisbon @2 Lisbon @3 PRT @Z 4 aut. @Z 10 aut.
A14 06      @1 Neurology Service, Hospital Clínic, Barcelona, Spain, Institut D'Investigació Biomèdiques August Pi i Sunyer (IDIBAPS), CIBERNED @2 Barcelona @3 ESP @Z 5 aut.
A14 07      @1 Department of Biometry and Epidemiology, Medical University of South Carolina @2 Charleston, South Carolina @3 USA @Z 6 aut.
A14 08      @1 Department of Clinical Neurophysiology, University of Göttingen, Paracelsus-Elena Klinik @2 K @3 DEU @Z 7 aut.
A14 09      @1 Department of Clinical Pharmacology, Toulouse University Hospital @2 Toulouse @3 FRA @Z 9 aut.
A14 10      @1 Department of Clinical Neurology, University College London @3 GBR @Z 12 aut.
A20       @1 2704-2716
A21       @1 2010
A23 01      @0 ENG
A43 01      @1 INIST @2 20953 @5 354000193512620020
A44       @0 0000 @1 © 2011 INIST-CNRS. All rights reserved.
A45       @0 113 ref.
A47 01  1    @0 11-0065107
A60       @1 P
A61       @0 A
A64 01  1    @0 Movement disorders
A66 01      @0 USA
C01 01    ENG  @0 There is a broad spectrum of sleep disturbances observed in Parkinson's disease (PD). A variety of scales have been applied to the evaluation of PD sleep and wakefulness, but only a small number have been assessed specifically for clinimetric properties in the PD population. The movement disorder society has commissioned this task force to examine these scales and to assess their use in PD. A systematic literature review was conducted to explore the use of sleep scales in PD and to determine which scales qualified for a detailed critique. The task force members, all of whom have extensive experience in assessing sleep in PD reviewed each of the scales using a structured proforma. Scales were categorized into recommended, suggested and listed according to predefined criteria. A total of 48 potential scales were identified from the search and reviewed. Twenty-nine were excluded because they did not meet review criteria or were variations of scales already included, leaving 19 scales that were critiqued and rated by the task force based on the rating criteria. Only six were found to meet criteria for recommendation or suggestion by the task force: the PD sleep scale (PDSS) and the Pittsburgh sleep quality index (PSQI) are recommended for rating overall sleep problems to screen and to measure severity, the SCOPA-sleep (SCOPA) is recommended for rating overall sleep problems both to screen and to measure severity, and for rating daytime sleepiness ; the Epworth sleepiness scale (ESS) is recommended for rating daytime sleepiness to screen and to measure severity; the inappropriate sleep composite score (ISCS) is suggested for rating severe daytime sleepiness or sleep attacks to screen and to measure severity; and the Stanford sleepiness scale (SSS) is suggested for rating sleepiness and to measure severity at a specific moment. The task force does not recommend the development of new scales, but emphasizes the need for educational efforts to train physicians in sleep interview techniques and polysomnography.
C02 01  X    @0 002B17
C02 02  X    @0 002B17G
C03 01  X  FRE  @0 Trouble du sommeil @5 01
C03 01  X  ENG  @0 Sleep disorder @5 01
C03 01  X  SPA  @0 Trastorno sueño @5 01
C03 02  X  FRE  @0 Maladie de Parkinson @2 NM @5 02
C03 02  X  ENG  @0 Parkinson disease @2 NM @5 02
C03 02  X  SPA  @0 Parkinson enfermedad @2 NM @5 02
C03 03  X  FRE  @0 Pathologie du système nerveux @5 03
C03 03  X  ENG  @0 Nervous system diseases @5 03
C03 03  X  SPA  @0 Sistema nervioso patología @5 03
C03 04  X  FRE  @0 Recommandation @5 09
C03 04  X  ENG  @0 Recommendation @5 09
C03 04  X  SPA  @0 Recomendación @5 09
C03 05  X  FRE  @0 Sommeil @5 10
C03 05  X  ENG  @0 Sleep @5 10
C03 05  X  SPA  @0 Sueño @5 10
C03 06  X  FRE  @0 Questionnaire @5 11
C03 06  X  ENG  @0 Questionnaire @5 11
C03 06  X  SPA  @0 Cuestionario @5 11
C07 01  X  FRE  @0 Trouble neurologique @5 38
C07 01  X  ENG  @0 Neurological disorder @5 38
C07 01  X  SPA  @0 Trastorno neurológico @5 38
C07 02  X  FRE  @0 Pathologie de l'encéphale @5 39
C07 02  X  ENG  @0 Cerebral disorder @5 39
C07 02  X  SPA  @0 Encéfalo patología @5 39
C07 03  X  FRE  @0 Syndrome extrapyramidal @5 40
C07 03  X  ENG  @0 Extrapyramidal syndrome @5 40
C07 03  X  SPA  @0 Extrapiramidal síndrome @5 40
C07 04  X  FRE  @0 Maladie dégénérative @5 41
C07 04  X  ENG  @0 Degenerative disease @5 41
C07 04  X  SPA  @0 Enfermedad degenerativa @5 41
C07 05  X  FRE  @0 Pathologie du système nerveux central @5 42
C07 05  X  ENG  @0 Central nervous system disease @5 42
C07 05  X  SPA  @0 Sistema nervosio central patología @5 42
C07 06  X  FRE  @0 Cycle veille sommeil @5 43
C07 06  X  ENG  @0 Sleep wake cycle @5 43
C07 06  X  SPA  @0 Ciclo sueño vigilia @5 43
N21       @1 045
N44 01      @1 OTO
N82       @1 OTO

Format Inist (serveur)

NO : PASCAL 11-0065107 INIST
ET : Scales to Assess Sleep Impairment in Parkinson's Disease: Critique and Recommendations
AU : HÖGL (Birgit); ARNULF (Isabelle); COMELLA (Cynthia); FERREIRA (Joaquim); IRANZO (Alex); TILLEY (Barbara); TRENKWALDER (Claudia); POEWE (Werner); RASCOL (Olivier); SAMPAIO (Cristina); STEBBINS (Glenn T.); SCHRAG (Anette); GOETZ (Christopher G.)
AF : Department of Neurology, Innsbruck Medical University/Innsbruck/Autriche (1 aut., 8 aut.); Unité des Pathologies du Sommeil, Hôpital Pitié-Salpêtrière/Paris/France (2 aut.); UMR975, Université Paris VI/Paris/France (2 aut.); Department of Neurological Sciences, Rush University Medical Center/Chicago, Illinois/Etats-Unis (3 aut., 11 aut., 13 aut.); Instituto de Medicina Molecular, University of Lisbon/Lisbon/Portugal (4 aut., 10 aut.); Neurology Service, Hospital Clínic, Barcelona, Spain, Institut D'Investigació Biomèdiques August Pi i Sunyer (IDIBAPS), CIBERNED/Barcelona/Espagne (5 aut.); Department of Biometry and Epidemiology, Medical University of South Carolina/Charleston, South Carolina/Etats-Unis (6 aut.); Department of Clinical Neurophysiology, University of Göttingen, Paracelsus-Elena Klinik/K/Allemagne (7 aut.); Department of Clinical Pharmacology, Toulouse University Hospital/Toulouse/France (9 aut.); Department of Clinical Neurology, University College London/Royaume-Uni (12 aut.)
DT : Publication en série; Niveau analytique
SO : Movement disorders; ISSN 0885-3185; Etats-Unis; Da. 2010; Vol. 25; No. 16; Pp. 2704-2716; Bibl. 113 ref.
LA : Anglais
EA : There is a broad spectrum of sleep disturbances observed in Parkinson's disease (PD). A variety of scales have been applied to the evaluation of PD sleep and wakefulness, but only a small number have been assessed specifically for clinimetric properties in the PD population. The movement disorder society has commissioned this task force to examine these scales and to assess their use in PD. A systematic literature review was conducted to explore the use of sleep scales in PD and to determine which scales qualified for a detailed critique. The task force members, all of whom have extensive experience in assessing sleep in PD reviewed each of the scales using a structured proforma. Scales were categorized into recommended, suggested and listed according to predefined criteria. A total of 48 potential scales were identified from the search and reviewed. Twenty-nine were excluded because they did not meet review criteria or were variations of scales already included, leaving 19 scales that were critiqued and rated by the task force based on the rating criteria. Only six were found to meet criteria for recommendation or suggestion by the task force: the PD sleep scale (PDSS) and the Pittsburgh sleep quality index (PSQI) are recommended for rating overall sleep problems to screen and to measure severity, the SCOPA-sleep (SCOPA) is recommended for rating overall sleep problems both to screen and to measure severity, and for rating daytime sleepiness ; the Epworth sleepiness scale (ESS) is recommended for rating daytime sleepiness to screen and to measure severity; the inappropriate sleep composite score (ISCS) is suggested for rating severe daytime sleepiness or sleep attacks to screen and to measure severity; and the Stanford sleepiness scale (SSS) is suggested for rating sleepiness and to measure severity at a specific moment. The task force does not recommend the development of new scales, but emphasizes the need for educational efforts to train physicians in sleep interview techniques and polysomnography.
CC : 002B17; 002B17G
FD : Trouble du sommeil; Maladie de Parkinson; Pathologie du système nerveux; Recommandation; Sommeil; Questionnaire
FG : Trouble neurologique; Pathologie de l'encéphale; Syndrome extrapyramidal; Maladie dégénérative; Pathologie du système nerveux central; Cycle veille sommeil
ED : Sleep disorder; Parkinson disease; Nervous system diseases; Recommendation; Sleep; Questionnaire
EG : Neurological disorder; Cerebral disorder; Extrapyramidal syndrome; Degenerative disease; Central nervous system disease; Sleep wake cycle
SD : Trastorno sueño; Parkinson enfermedad; Sistema nervioso patología; Recomendación; Sueño; Cuestionario
LO : INIST-20953.354000193512620020
ID : 11-0065107

Links to Exploration step

Pascal:11-0065107

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en" level="a">Scales to Assess Sleep Impairment in Parkinson's Disease: Critique and Recommendations</title>
<author>
<name sortKey="Hogl, Birgit" sort="Hogl, Birgit" uniqKey="Hogl B" first="Birgit" last="Högl">Birgit Högl</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Department of Neurology, Innsbruck Medical University</s1>
<s2>Innsbruck</s2>
<s3>AUT</s3>
<sZ>1 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Arnulf, Isabelle" sort="Arnulf, Isabelle" uniqKey="Arnulf I" first="Isabelle" last="Arnulf">Isabelle Arnulf</name>
<affiliation>
<inist:fA14 i1="02">
<s1>Unité des Pathologies du Sommeil, Hôpital Pitié-Salpêtrière</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>2 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation>
<inist:fA14 i1="03">
<s1>UMR975, Université Paris VI</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>2 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Comella, Cynthia" sort="Comella, Cynthia" uniqKey="Comella C" first="Cynthia" last="Comella">Cynthia Comella</name>
<affiliation>
<inist:fA14 i1="04">
<s1>Department of Neurological Sciences, Rush University Medical Center</s1>
<s2>Chicago, Illinois</s2>
<s3>USA</s3>
<sZ>3 aut.</sZ>
<sZ>11 aut.</sZ>
<sZ>13 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Ferreira, Joaquim" sort="Ferreira, Joaquim" uniqKey="Ferreira J" first="Joaquim" last="Ferreira">Joaquim Ferreira</name>
<affiliation>
<inist:fA14 i1="05">
<s1>Instituto de Medicina Molecular, University of Lisbon</s1>
<s2>Lisbon</s2>
<s3>PRT</s3>
<sZ>4 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Iranzo, Alex" sort="Iranzo, Alex" uniqKey="Iranzo A" first="Alex" last="Iranzo">Alex Iranzo</name>
<affiliation>
<inist:fA14 i1="06">
<s1>Neurology Service, Hospital Clínic, Barcelona, Spain, Institut D'Investigació Biomèdiques August Pi i Sunyer (IDIBAPS), CIBERNED</s1>
<s2>Barcelona</s2>
<s3>ESP</s3>
<sZ>5 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Tilley, Barbara" sort="Tilley, Barbara" uniqKey="Tilley B" first="Barbara" last="Tilley">Barbara Tilley</name>
<affiliation>
<inist:fA14 i1="07">
<s1>Department of Biometry and Epidemiology, Medical University of South Carolina</s1>
<s2>Charleston, South Carolina</s2>
<s3>USA</s3>
<sZ>6 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Trenkwalder, Claudia" sort="Trenkwalder, Claudia" uniqKey="Trenkwalder C" first="Claudia" last="Trenkwalder">Claudia Trenkwalder</name>
<affiliation>
<inist:fA14 i1="08">
<s1>Department of Clinical Neurophysiology, University of Göttingen, Paracelsus-Elena Klinik</s1>
<s2>K</s2>
<s3>DEU</s3>
<sZ>7 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Poewe, Werner" sort="Poewe, Werner" uniqKey="Poewe W" first="Werner" last="Poewe">Werner Poewe</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Department of Neurology, Innsbruck Medical University</s1>
<s2>Innsbruck</s2>
<s3>AUT</s3>
<sZ>1 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Rascol, Olivier" sort="Rascol, Olivier" uniqKey="Rascol O" first="Olivier" last="Rascol">Olivier Rascol</name>
<affiliation>
<inist:fA14 i1="09">
<s1>Department of Clinical Pharmacology, Toulouse University Hospital</s1>
<s2>Toulouse</s2>
<s3>FRA</s3>
<sZ>9 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Sampaio, Cristina" sort="Sampaio, Cristina" uniqKey="Sampaio C" first="Cristina" last="Sampaio">Cristina Sampaio</name>
<affiliation>
<inist:fA14 i1="05">
<s1>Instituto de Medicina Molecular, University of Lisbon</s1>
<s2>Lisbon</s2>
<s3>PRT</s3>
<sZ>4 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Stebbins, Glenn T" sort="Stebbins, Glenn T" uniqKey="Stebbins G" first="Glenn T." last="Stebbins">Glenn T. Stebbins</name>
<affiliation>
<inist:fA14 i1="04">
<s1>Department of Neurological Sciences, Rush University Medical Center</s1>
<s2>Chicago, Illinois</s2>
<s3>USA</s3>
<sZ>3 aut.</sZ>
<sZ>11 aut.</sZ>
<sZ>13 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Schrag, Anette" sort="Schrag, Anette" uniqKey="Schrag A" first="Anette" last="Schrag">Anette Schrag</name>
<affiliation>
<inist:fA14 i1="10">
<s1>Department of Clinical Neurology, University College London</s1>
<s3>GBR</s3>
<sZ>12 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Goetz, Christopher G" sort="Goetz, Christopher G" uniqKey="Goetz C" first="Christopher G." last="Goetz">Christopher G. Goetz</name>
<affiliation>
<inist:fA14 i1="04">
<s1>Department of Neurological Sciences, Rush University Medical Center</s1>
<s2>Chicago, Illinois</s2>
<s3>USA</s3>
<sZ>3 aut.</sZ>
<sZ>11 aut.</sZ>
<sZ>13 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">INIST</idno>
<idno type="inist">11-0065107</idno>
<date when="2010">2010</date>
<idno type="stanalyst">PASCAL 11-0065107 INIST</idno>
<idno type="RBID">Pascal:11-0065107</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000786</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en" level="a">Scales to Assess Sleep Impairment in Parkinson's Disease: Critique and Recommendations</title>
<author>
<name sortKey="Hogl, Birgit" sort="Hogl, Birgit" uniqKey="Hogl B" first="Birgit" last="Högl">Birgit Högl</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Department of Neurology, Innsbruck Medical University</s1>
<s2>Innsbruck</s2>
<s3>AUT</s3>
<sZ>1 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Arnulf, Isabelle" sort="Arnulf, Isabelle" uniqKey="Arnulf I" first="Isabelle" last="Arnulf">Isabelle Arnulf</name>
<affiliation>
<inist:fA14 i1="02">
<s1>Unité des Pathologies du Sommeil, Hôpital Pitié-Salpêtrière</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>2 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation>
<inist:fA14 i1="03">
<s1>UMR975, Université Paris VI</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>2 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Comella, Cynthia" sort="Comella, Cynthia" uniqKey="Comella C" first="Cynthia" last="Comella">Cynthia Comella</name>
<affiliation>
<inist:fA14 i1="04">
<s1>Department of Neurological Sciences, Rush University Medical Center</s1>
<s2>Chicago, Illinois</s2>
<s3>USA</s3>
<sZ>3 aut.</sZ>
<sZ>11 aut.</sZ>
<sZ>13 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Ferreira, Joaquim" sort="Ferreira, Joaquim" uniqKey="Ferreira J" first="Joaquim" last="Ferreira">Joaquim Ferreira</name>
<affiliation>
<inist:fA14 i1="05">
<s1>Instituto de Medicina Molecular, University of Lisbon</s1>
<s2>Lisbon</s2>
<s3>PRT</s3>
<sZ>4 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Iranzo, Alex" sort="Iranzo, Alex" uniqKey="Iranzo A" first="Alex" last="Iranzo">Alex Iranzo</name>
<affiliation>
<inist:fA14 i1="06">
<s1>Neurology Service, Hospital Clínic, Barcelona, Spain, Institut D'Investigació Biomèdiques August Pi i Sunyer (IDIBAPS), CIBERNED</s1>
<s2>Barcelona</s2>
<s3>ESP</s3>
<sZ>5 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Tilley, Barbara" sort="Tilley, Barbara" uniqKey="Tilley B" first="Barbara" last="Tilley">Barbara Tilley</name>
<affiliation>
<inist:fA14 i1="07">
<s1>Department of Biometry and Epidemiology, Medical University of South Carolina</s1>
<s2>Charleston, South Carolina</s2>
<s3>USA</s3>
<sZ>6 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Trenkwalder, Claudia" sort="Trenkwalder, Claudia" uniqKey="Trenkwalder C" first="Claudia" last="Trenkwalder">Claudia Trenkwalder</name>
<affiliation>
<inist:fA14 i1="08">
<s1>Department of Clinical Neurophysiology, University of Göttingen, Paracelsus-Elena Klinik</s1>
<s2>K</s2>
<s3>DEU</s3>
<sZ>7 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Poewe, Werner" sort="Poewe, Werner" uniqKey="Poewe W" first="Werner" last="Poewe">Werner Poewe</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Department of Neurology, Innsbruck Medical University</s1>
<s2>Innsbruck</s2>
<s3>AUT</s3>
<sZ>1 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Rascol, Olivier" sort="Rascol, Olivier" uniqKey="Rascol O" first="Olivier" last="Rascol">Olivier Rascol</name>
<affiliation>
<inist:fA14 i1="09">
<s1>Department of Clinical Pharmacology, Toulouse University Hospital</s1>
<s2>Toulouse</s2>
<s3>FRA</s3>
<sZ>9 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Sampaio, Cristina" sort="Sampaio, Cristina" uniqKey="Sampaio C" first="Cristina" last="Sampaio">Cristina Sampaio</name>
<affiliation>
<inist:fA14 i1="05">
<s1>Instituto de Medicina Molecular, University of Lisbon</s1>
<s2>Lisbon</s2>
<s3>PRT</s3>
<sZ>4 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Stebbins, Glenn T" sort="Stebbins, Glenn T" uniqKey="Stebbins G" first="Glenn T." last="Stebbins">Glenn T. Stebbins</name>
<affiliation>
<inist:fA14 i1="04">
<s1>Department of Neurological Sciences, Rush University Medical Center</s1>
<s2>Chicago, Illinois</s2>
<s3>USA</s3>
<sZ>3 aut.</sZ>
<sZ>11 aut.</sZ>
<sZ>13 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Schrag, Anette" sort="Schrag, Anette" uniqKey="Schrag A" first="Anette" last="Schrag">Anette Schrag</name>
<affiliation>
<inist:fA14 i1="10">
<s1>Department of Clinical Neurology, University College London</s1>
<s3>GBR</s3>
<sZ>12 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Goetz, Christopher G" sort="Goetz, Christopher G" uniqKey="Goetz C" first="Christopher G." last="Goetz">Christopher G. Goetz</name>
<affiliation>
<inist:fA14 i1="04">
<s1>Department of Neurological Sciences, Rush University Medical Center</s1>
<s2>Chicago, Illinois</s2>
<s3>USA</s3>
<sZ>3 aut.</sZ>
<sZ>11 aut.</sZ>
<sZ>13 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</analytic>
<series>
<title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
<imprint>
<date when="2010">2010</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Nervous system diseases</term>
<term>Parkinson disease</term>
<term>Questionnaire</term>
<term>Recommendation</term>
<term>Sleep</term>
<term>Sleep disorder</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr">
<term>Trouble du sommeil</term>
<term>Maladie de Parkinson</term>
<term>Pathologie du système nerveux</term>
<term>Recommandation</term>
<term>Sommeil</term>
<term>Questionnaire</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">There is a broad spectrum of sleep disturbances observed in Parkinson's disease (PD). A variety of scales have been applied to the evaluation of PD sleep and wakefulness, but only a small number have been assessed specifically for clinimetric properties in the PD population. The movement disorder society has commissioned this task force to examine these scales and to assess their use in PD. A systematic literature review was conducted to explore the use of sleep scales in PD and to determine which scales qualified for a detailed critique. The task force members, all of whom have extensive experience in assessing sleep in PD reviewed each of the scales using a structured proforma. Scales were categorized into recommended, suggested and listed according to predefined criteria. A total of 48 potential scales were identified from the search and reviewed. Twenty-nine were excluded because they did not meet review criteria or were variations of scales already included, leaving 19 scales that were critiqued and rated by the task force based on the rating criteria. Only six were found to meet criteria for recommendation or suggestion by the task force: the PD sleep scale (PDSS) and the Pittsburgh sleep quality index (PSQI) are recommended for rating overall sleep problems to screen and to measure severity, the SCOPA-sleep (SCOPA) is recommended for rating overall sleep problems both to screen and to measure severity, and for rating daytime sleepiness ; the Epworth sleepiness scale (ESS) is recommended for rating daytime sleepiness to screen and to measure severity; the inappropriate sleep composite score (ISCS) is suggested for rating severe daytime sleepiness or sleep attacks to screen and to measure severity; and the Stanford sleepiness scale (SSS) is suggested for rating sleepiness and to measure severity at a specific moment. The task force does not recommend the development of new scales, but emphasizes the need for educational efforts to train physicians in sleep interview techniques and polysomnography.</div>
</front>
</TEI>
<inist>
<standard h6="B">
<pA>
<fA01 i1="01" i2="1">
<s0>0885-3185</s0>
</fA01>
<fA03 i2="1">
<s0>Mov. disord.</s0>
</fA03>
<fA05>
<s2>25</s2>
</fA05>
<fA06>
<s2>16</s2>
</fA06>
<fA08 i1="01" i2="1" l="ENG">
<s1>Scales to Assess Sleep Impairment in Parkinson's Disease: Critique and Recommendations</s1>
</fA08>
<fA11 i1="01" i2="1">
<s1>HÖGL (Birgit)</s1>
</fA11>
<fA11 i1="02" i2="1">
<s1>ARNULF (Isabelle)</s1>
</fA11>
<fA11 i1="03" i2="1">
<s1>COMELLA (Cynthia)</s1>
</fA11>
<fA11 i1="04" i2="1">
<s1>FERREIRA (Joaquim)</s1>
</fA11>
<fA11 i1="05" i2="1">
<s1>IRANZO (Alex)</s1>
</fA11>
<fA11 i1="06" i2="1">
<s1>TILLEY (Barbara)</s1>
</fA11>
<fA11 i1="07" i2="1">
<s1>TRENKWALDER (Claudia)</s1>
</fA11>
<fA11 i1="08" i2="1">
<s1>POEWE (Werner)</s1>
</fA11>
<fA11 i1="09" i2="1">
<s1>RASCOL (Olivier)</s1>
</fA11>
<fA11 i1="10" i2="1">
<s1>SAMPAIO (Cristina)</s1>
</fA11>
<fA11 i1="11" i2="1">
<s1>STEBBINS (Glenn T.)</s1>
</fA11>
<fA11 i1="12" i2="1">
<s1>SCHRAG (Anette)</s1>
</fA11>
<fA11 i1="13" i2="1">
<s1>GOETZ (Christopher G.)</s1>
</fA11>
<fA14 i1="01">
<s1>Department of Neurology, Innsbruck Medical University</s1>
<s2>Innsbruck</s2>
<s3>AUT</s3>
<sZ>1 aut.</sZ>
<sZ>8 aut.</sZ>
</fA14>
<fA14 i1="02">
<s1>Unité des Pathologies du Sommeil, Hôpital Pitié-Salpêtrière</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>2 aut.</sZ>
</fA14>
<fA14 i1="03">
<s1>UMR975, Université Paris VI</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>2 aut.</sZ>
</fA14>
<fA14 i1="04">
<s1>Department of Neurological Sciences, Rush University Medical Center</s1>
<s2>Chicago, Illinois</s2>
<s3>USA</s3>
<sZ>3 aut.</sZ>
<sZ>11 aut.</sZ>
<sZ>13 aut.</sZ>
</fA14>
<fA14 i1="05">
<s1>Instituto de Medicina Molecular, University of Lisbon</s1>
<s2>Lisbon</s2>
<s3>PRT</s3>
<sZ>4 aut.</sZ>
<sZ>10 aut.</sZ>
</fA14>
<fA14 i1="06">
<s1>Neurology Service, Hospital Clínic, Barcelona, Spain, Institut D'Investigació Biomèdiques August Pi i Sunyer (IDIBAPS), CIBERNED</s1>
<s2>Barcelona</s2>
<s3>ESP</s3>
<sZ>5 aut.</sZ>
</fA14>
<fA14 i1="07">
<s1>Department of Biometry and Epidemiology, Medical University of South Carolina</s1>
<s2>Charleston, South Carolina</s2>
<s3>USA</s3>
<sZ>6 aut.</sZ>
</fA14>
<fA14 i1="08">
<s1>Department of Clinical Neurophysiology, University of Göttingen, Paracelsus-Elena Klinik</s1>
<s2>K</s2>
<s3>DEU</s3>
<sZ>7 aut.</sZ>
</fA14>
<fA14 i1="09">
<s1>Department of Clinical Pharmacology, Toulouse University Hospital</s1>
<s2>Toulouse</s2>
<s3>FRA</s3>
<sZ>9 aut.</sZ>
</fA14>
<fA14 i1="10">
<s1>Department of Clinical Neurology, University College London</s1>
<s3>GBR</s3>
<sZ>12 aut.</sZ>
</fA14>
<fA20>
<s1>2704-2716</s1>
</fA20>
<fA21>
<s1>2010</s1>
</fA21>
<fA23 i1="01">
<s0>ENG</s0>
</fA23>
<fA43 i1="01">
<s1>INIST</s1>
<s2>20953</s2>
<s5>354000193512620020</s5>
</fA43>
<fA44>
<s0>0000</s0>
<s1>© 2011 INIST-CNRS. All rights reserved.</s1>
</fA44>
<fA45>
<s0>113 ref.</s0>
</fA45>
<fA47 i1="01" i2="1">
<s0>11-0065107</s0>
</fA47>
<fA60>
<s1>P</s1>
</fA60>
<fA61>
<s0>A</s0>
</fA61>
<fA64 i1="01" i2="1">
<s0>Movement disorders</s0>
</fA64>
<fA66 i1="01">
<s0>USA</s0>
</fA66>
<fC01 i1="01" l="ENG">
<s0>There is a broad spectrum of sleep disturbances observed in Parkinson's disease (PD). A variety of scales have been applied to the evaluation of PD sleep and wakefulness, but only a small number have been assessed specifically for clinimetric properties in the PD population. The movement disorder society has commissioned this task force to examine these scales and to assess their use in PD. A systematic literature review was conducted to explore the use of sleep scales in PD and to determine which scales qualified for a detailed critique. The task force members, all of whom have extensive experience in assessing sleep in PD reviewed each of the scales using a structured proforma. Scales were categorized into recommended, suggested and listed according to predefined criteria. A total of 48 potential scales were identified from the search and reviewed. Twenty-nine were excluded because they did not meet review criteria or were variations of scales already included, leaving 19 scales that were critiqued and rated by the task force based on the rating criteria. Only six were found to meet criteria for recommendation or suggestion by the task force: the PD sleep scale (PDSS) and the Pittsburgh sleep quality index (PSQI) are recommended for rating overall sleep problems to screen and to measure severity, the SCOPA-sleep (SCOPA) is recommended for rating overall sleep problems both to screen and to measure severity, and for rating daytime sleepiness ; the Epworth sleepiness scale (ESS) is recommended for rating daytime sleepiness to screen and to measure severity; the inappropriate sleep composite score (ISCS) is suggested for rating severe daytime sleepiness or sleep attacks to screen and to measure severity; and the Stanford sleepiness scale (SSS) is suggested for rating sleepiness and to measure severity at a specific moment. The task force does not recommend the development of new scales, but emphasizes the need for educational efforts to train physicians in sleep interview techniques and polysomnography.</s0>
</fC01>
<fC02 i1="01" i2="X">
<s0>002B17</s0>
</fC02>
<fC02 i1="02" i2="X">
<s0>002B17G</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE">
<s0>Trouble du sommeil</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="ENG">
<s0>Sleep disorder</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="SPA">
<s0>Trastorno sueño</s0>
<s5>01</s5>
</fC03>
<fC03 i1="02" i2="X" l="FRE">
<s0>Maladie de Parkinson</s0>
<s2>NM</s2>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="ENG">
<s0>Parkinson disease</s0>
<s2>NM</s2>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="SPA">
<s0>Parkinson enfermedad</s0>
<s2>NM</s2>
<s5>02</s5>
</fC03>
<fC03 i1="03" i2="X" l="FRE">
<s0>Pathologie du système nerveux</s0>
<s5>03</s5>
</fC03>
<fC03 i1="03" i2="X" l="ENG">
<s0>Nervous system diseases</s0>
<s5>03</s5>
</fC03>
<fC03 i1="03" i2="X" l="SPA">
<s0>Sistema nervioso patología</s0>
<s5>03</s5>
</fC03>
<fC03 i1="04" i2="X" l="FRE">
<s0>Recommandation</s0>
<s5>09</s5>
</fC03>
<fC03 i1="04" i2="X" l="ENG">
<s0>Recommendation</s0>
<s5>09</s5>
</fC03>
<fC03 i1="04" i2="X" l="SPA">
<s0>Recomendación</s0>
<s5>09</s5>
</fC03>
<fC03 i1="05" i2="X" l="FRE">
<s0>Sommeil</s0>
<s5>10</s5>
</fC03>
<fC03 i1="05" i2="X" l="ENG">
<s0>Sleep</s0>
<s5>10</s5>
</fC03>
<fC03 i1="05" i2="X" l="SPA">
<s0>Sueño</s0>
<s5>10</s5>
</fC03>
<fC03 i1="06" i2="X" l="FRE">
<s0>Questionnaire</s0>
<s5>11</s5>
</fC03>
<fC03 i1="06" i2="X" l="ENG">
<s0>Questionnaire</s0>
<s5>11</s5>
</fC03>
<fC03 i1="06" i2="X" l="SPA">
<s0>Cuestionario</s0>
<s5>11</s5>
</fC03>
<fC07 i1="01" i2="X" l="FRE">
<s0>Trouble neurologique</s0>
<s5>38</s5>
</fC07>
<fC07 i1="01" i2="X" l="ENG">
<s0>Neurological disorder</s0>
<s5>38</s5>
</fC07>
<fC07 i1="01" i2="X" l="SPA">
<s0>Trastorno neurológico</s0>
<s5>38</s5>
</fC07>
<fC07 i1="02" i2="X" l="FRE">
<s0>Pathologie de l'encéphale</s0>
<s5>39</s5>
</fC07>
<fC07 i1="02" i2="X" l="ENG">
<s0>Cerebral disorder</s0>
<s5>39</s5>
</fC07>
<fC07 i1="02" i2="X" l="SPA">
<s0>Encéfalo patología</s0>
<s5>39</s5>
</fC07>
<fC07 i1="03" i2="X" l="FRE">
<s0>Syndrome extrapyramidal</s0>
<s5>40</s5>
</fC07>
<fC07 i1="03" i2="X" l="ENG">
<s0>Extrapyramidal syndrome</s0>
<s5>40</s5>
</fC07>
<fC07 i1="03" i2="X" l="SPA">
<s0>Extrapiramidal síndrome</s0>
<s5>40</s5>
</fC07>
<fC07 i1="04" i2="X" l="FRE">
<s0>Maladie dégénérative</s0>
<s5>41</s5>
</fC07>
<fC07 i1="04" i2="X" l="ENG">
<s0>Degenerative disease</s0>
<s5>41</s5>
</fC07>
<fC07 i1="04" i2="X" l="SPA">
<s0>Enfermedad degenerativa</s0>
<s5>41</s5>
</fC07>
<fC07 i1="05" i2="X" l="FRE">
<s0>Pathologie du système nerveux central</s0>
<s5>42</s5>
</fC07>
<fC07 i1="05" i2="X" l="ENG">
<s0>Central nervous system disease</s0>
<s5>42</s5>
</fC07>
<fC07 i1="05" i2="X" l="SPA">
<s0>Sistema nervosio central patología</s0>
<s5>42</s5>
</fC07>
<fC07 i1="06" i2="X" l="FRE">
<s0>Cycle veille sommeil</s0>
<s5>43</s5>
</fC07>
<fC07 i1="06" i2="X" l="ENG">
<s0>Sleep wake cycle</s0>
<s5>43</s5>
</fC07>
<fC07 i1="06" i2="X" l="SPA">
<s0>Ciclo sueño vigilia</s0>
<s5>43</s5>
</fC07>
<fN21>
<s1>045</s1>
</fN21>
<fN44 i1="01">
<s1>OTO</s1>
</fN44>
<fN82>
<s1>OTO</s1>
</fN82>
</pA>
</standard>
<server>
<NO>PASCAL 11-0065107 INIST</NO>
<ET>Scales to Assess Sleep Impairment in Parkinson's Disease: Critique and Recommendations</ET>
<AU>HÖGL (Birgit); ARNULF (Isabelle); COMELLA (Cynthia); FERREIRA (Joaquim); IRANZO (Alex); TILLEY (Barbara); TRENKWALDER (Claudia); POEWE (Werner); RASCOL (Olivier); SAMPAIO (Cristina); STEBBINS (Glenn T.); SCHRAG (Anette); GOETZ (Christopher G.)</AU>
<AF>Department of Neurology, Innsbruck Medical University/Innsbruck/Autriche (1 aut., 8 aut.); Unité des Pathologies du Sommeil, Hôpital Pitié-Salpêtrière/Paris/France (2 aut.); UMR975, Université Paris VI/Paris/France (2 aut.); Department of Neurological Sciences, Rush University Medical Center/Chicago, Illinois/Etats-Unis (3 aut., 11 aut., 13 aut.); Instituto de Medicina Molecular, University of Lisbon/Lisbon/Portugal (4 aut., 10 aut.); Neurology Service, Hospital Clínic, Barcelona, Spain, Institut D'Investigació Biomèdiques August Pi i Sunyer (IDIBAPS), CIBERNED/Barcelona/Espagne (5 aut.); Department of Biometry and Epidemiology, Medical University of South Carolina/Charleston, South Carolina/Etats-Unis (6 aut.); Department of Clinical Neurophysiology, University of Göttingen, Paracelsus-Elena Klinik/K/Allemagne (7 aut.); Department of Clinical Pharmacology, Toulouse University Hospital/Toulouse/France (9 aut.); Department of Clinical Neurology, University College London/Royaume-Uni (12 aut.)</AF>
<DT>Publication en série; Niveau analytique</DT>
<SO>Movement disorders; ISSN 0885-3185; Etats-Unis; Da. 2010; Vol. 25; No. 16; Pp. 2704-2716; Bibl. 113 ref.</SO>
<LA>Anglais</LA>
<EA>There is a broad spectrum of sleep disturbances observed in Parkinson's disease (PD). A variety of scales have been applied to the evaluation of PD sleep and wakefulness, but only a small number have been assessed specifically for clinimetric properties in the PD population. The movement disorder society has commissioned this task force to examine these scales and to assess their use in PD. A systematic literature review was conducted to explore the use of sleep scales in PD and to determine which scales qualified for a detailed critique. The task force members, all of whom have extensive experience in assessing sleep in PD reviewed each of the scales using a structured proforma. Scales were categorized into recommended, suggested and listed according to predefined criteria. A total of 48 potential scales were identified from the search and reviewed. Twenty-nine were excluded because they did not meet review criteria or were variations of scales already included, leaving 19 scales that were critiqued and rated by the task force based on the rating criteria. Only six were found to meet criteria for recommendation or suggestion by the task force: the PD sleep scale (PDSS) and the Pittsburgh sleep quality index (PSQI) are recommended for rating overall sleep problems to screen and to measure severity, the SCOPA-sleep (SCOPA) is recommended for rating overall sleep problems both to screen and to measure severity, and for rating daytime sleepiness ; the Epworth sleepiness scale (ESS) is recommended for rating daytime sleepiness to screen and to measure severity; the inappropriate sleep composite score (ISCS) is suggested for rating severe daytime sleepiness or sleep attacks to screen and to measure severity; and the Stanford sleepiness scale (SSS) is suggested for rating sleepiness and to measure severity at a specific moment. The task force does not recommend the development of new scales, but emphasizes the need for educational efforts to train physicians in sleep interview techniques and polysomnography.</EA>
<CC>002B17; 002B17G</CC>
<FD>Trouble du sommeil; Maladie de Parkinson; Pathologie du système nerveux; Recommandation; Sommeil; Questionnaire</FD>
<FG>Trouble neurologique; Pathologie de l'encéphale; Syndrome extrapyramidal; Maladie dégénérative; Pathologie du système nerveux central; Cycle veille sommeil</FG>
<ED>Sleep disorder; Parkinson disease; Nervous system diseases; Recommendation; Sleep; Questionnaire</ED>
<EG>Neurological disorder; Cerebral disorder; Extrapyramidal syndrome; Degenerative disease; Central nervous system disease; Sleep wake cycle</EG>
<SD>Trastorno sueño; Parkinson enfermedad; Sistema nervioso patología; Recomendación; Sueño; Cuestionario</SD>
<LO>INIST-20953.354000193512620020</LO>
<ID>11-0065107</ID>
</server>
</inist>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/PascalFrancis/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000786 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Corpus/biblio.hfd -nk 000786 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    PascalFrancis
   |étape=   Corpus
   |type=    RBID
   |clé=     Pascal:11-0065107
   |texte=   Scales to Assess Sleep Impairment in Parkinson's Disease: Critique and Recommendations
}}

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024